Form 4 for STE Steris
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-13 · accession 0001628280-24-023609 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-15 | 2024-05-13 | STE | Majors Cary L | SVP, Pres, Healthcare | S - Sale | $232.13 | -2,024 | 11.4K | -15% | -$469.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-05-13 | S | D | 2,024 | $232.13 | 11,369 | D | — | — | (F1) Price reflects a weighted average sale price for multiple transactions ranging from $231.9703 to $232.2750 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) As of May 13, 2024, 9,860 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026 and 2,140 on June 2, 2026. |